يعرض 1 - 10 نتائج من 80 نتيجة بحث عن '"Iacoboni G."', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

    المؤلفون: Rejeski, K, Subklewe, M, Aljurf, M, Bachy, E, Balduzzi, A, Barba, P, Bruno, B, Benjamin, R, Carrabba, MG, Chabannon, C, Ciceri, F, Corradini, P, Delgado, J, Di Blasi, R, Greco, R, Houot, R, Iacoboni, G, Jager, U, Kersten, MJ, Mielke, S, Nagler, A, Onida, F, Peric, Z, Roddie, C, Ruggeri, A, Sanchez-Guijo, F, Sanchez-Ortega, I, Schneidawind, D, Schubert, ML, Snowden, JA, Thieblemont, C, Topp, M, Zinzani, PL, Gribben, JG, Bonini, C, Sureda, A, Yakoub-Agha, I

    المصدر: Blood. 142(10):865-877

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:153951673Test

    View record in SwePub النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Inferior outcomes of EU versus US patients treated with CD19 CAR-T for relapsed/refractory large B-cell lymphoma: association with differences in tumor burden, systemic inflammation, bridging therapy utilization, and CAR-T product use

    المؤلفون: Bücklein, V., Perez, A., Rejeski, K., Iacoboni, G., Jurinovic, V., Holtick, U., Penack, O., Kharboutli, S., Blumenberg, V., Ackermann, J., Frölich, L., Johnson, G., Patel, K., Arciola, B., Mhaskar, R., Wood, A., Schmidt, C., Albanyan, O., Gödel, P., Hoster, E., Bullinger, L., Mackensen, A., Locke, F., von Bergwelt, M., Barba, P., Subklewe, M., Jain, M.D.

    مصطلحات موضوعية: Cancer Research

    وصف الملف: application/pdf; other

    العلاقة: http://edoc.mdc-berlin.de/23596/1/23596oa.pdfTest; http://edoc.mdc-berlin.de/23596/7/23596suppl.docxTest; Inferior outcomes of EU versus US patients treated with CD19 CAR-T for relapsed/refractory large B-cell lymphoma: association with differences in tumor burden, systemic inflammation, bridging therapy utilization, and CAR-T product use. Bücklein, V. and Perez, A. and Rejeski, K. and Iacoboni, G. and Jurinovic, V. and Holtick, U. and Penack, O. and Kharboutli, S. and Blumenberg, V. and Ackermann, J. and Frölich, L. and Johnson, G. and Patel, K. and Arciola, B. and Mhaskar, R. and Wood, A. and Schmidt, C. and Albanyan, O. and Gödel, P. and Hoster, E. and Bullinger, L. and Mackensen, A. and Locke, F. and von Bergwelt, M. and Barba, P. and Subklewe, M. and Jain, M.D. HemaSphere 7 (8): e907. August 2023

    الإتاحة: https://doi.org/10.1097/hs9.0000000000000907Test
    http://edoc.mdc-berlin.de/23596Test/
    https://edoc.mdc-berlin.de/23596Test/
    http://edoc.mdc-berlin.de/23596/1/23596oa.pdfTest
    http://edoc.mdc-berlin.de/23596/7/23596suppl.docxTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

    المؤلفون: Rejeski, K., Perez, A., Iacoboni, G., Blumenberg, V., Bücklein, V.L., Völkl, S., Penack, O., Albanyan, O., Stock, S., Müller, F., Karschnia, P., Petrera, A., Reid, K., Faramand, R., Davila, M.L., Modi, K., Dean, E.A., Bachmeier, C., von Bergwelt-Baildon, M., Locke, F.L., Bethge, W., Bullinger, L., Mackensen, A., Barba, P., Jain, M.D., Subklewe, M.

    مصطلحات موضوعية: Cancer Research

    وصف الملف: application/pdf

    العلاقة: http://edoc.mdc-berlin.de/23746/1/23746oa.pdfTest; http://edoc.mdc-berlin.de/23746/2/23746suppl.pdfTest; Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Rejeski, K. and Perez, A. and Iacoboni, G. and Blumenberg, V. and Bücklein, V.L. and Völkl, S. and Penack, O. and Albanyan, O. and Stock, S. and Müller, F. and Karschnia, P. and Petrera, A. and Reid, K. and Faramand, R. and Davila, M.L. and Modi, K. and Dean, E.A. and Bachmeier, C. and von Bergwelt-Baildon, M. and Locke, F.L. and Bethge, W. and Bullinger, L. and Mackensen, A. and Barba, P. and Jain, M.D. and Subklewe, M. Science Advances 9 (38): eadg3919. 22 September 2023

    الإتاحة: https://doi.org/10.1126/sciadv.adg3919Test
    http://edoc.mdc-berlin.de/23746Test/
    https://edoc.mdc-berlin.de/23746Test/
    http://edoc.mdc-berlin.de/23746/1/23746oa.pdfTest
    http://edoc.mdc-berlin.de/23746/2/23746suppl.pdfTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Immune effector cell-associated hematotoxicity (ICAHT): EHA/EBMT consensus grading and best practice recommendations

    المؤلفون: Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A.C., Barba, P., Bruno, B., Benjamin, R., Carrabba, M.G., Chabannon, C., Ciceri, F., Corradini, P., Delgado, J., Di Blasi, R., Greco, R., Houot, R., Iacoboni, G., Jaeger, U., Kersten, M.J., Mielke, S., Nagler, A., Onida, F., Peric, Z., Roddie, C., Ruggeri, A., Sanchez-Guijo, F.M., Sánchez-Ortega, I., Schneidawind, D., Schubert, M.-L., Snowden, J., Thieblemont, C., Topp, M.S., Zinzani, P.L., Gribben, J.G., Bonini, C., Sureda Balari, A., Yakoub-Agha, I.

    وصف الملف: text

    العلاقة: https://eprints.whiterose.ac.uk/200638/1/Rejeski%20et%20al%20ICAHT%20Blood%202023.pdfTest; Rejeski, K., Subklewe, M. orcid.org/0000-0003-3905-0251 , Aljurf, M. et al. (34 more authors) (2023) Immune effector cell-associated hematotoxicity (ICAHT): EHA/EBMT consensus grading and best practice recommendations. Blood Journal. 2023020578. ISSN 0006-4971

    الإتاحة: https://eprints.whiterose.ac.uk/200638Test/
    https://eprints.whiterose.ac.uk/200638/1/Rejeski%20et%20al%20ICAHT%20Blood%202023.pdfTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

    المؤلفون: Iacoboni G., Rejeski K., Villacampa G., van Doesum J. A., Chiappella A., Bonifazi F., Lopez-Corral L., van Aalderen M., Kwon M., Martinez-Cibrian N., Bramanti S., Reguera-Ortega J. L., Camacho-Arteaga L., Schmidt C., Marin-Niebla A., Kersten M. J., Garcia-Sancho A. M., Zinzani P. L., Corradini P., van Meerten T., Subklewe M., Barba P.

    المساهمون: Iacoboni G., Rejeski K., Villacampa G., van Doesum J.A., Chiappella A., Bonifazi F., Lopez-Corral L., van Aalderen M., Kwon M., Martinez-Cibrian N., Bramanti S., Reguera-Ortega J.L., Camacho-Arteaga L., Schmidt C., Marin-Niebla A., Kersten M.J., Garcia-Sancho A.M., Zinzani P.L., Corradini P., van Meerten T., Subklewe M., Barba P.

    مصطلحات موضوعية: Real-world, brexucabtagene autoleucel, relapsed refractory, mantle cell lymphoma

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35271707; info:eu-repo/semantics/altIdentifier/wos/WOS:000836434600006; volume:6; issue:12; firstpage:3606; lastpage:3610; numberofpages:5; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/904780Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85132841958; https://ashpublications.org/bloodadvances/article/6/12/3606/484368/Real-world-evidence-of-brexucabtagene-autoleucelTest

    الإتاحة: https://doi.org/10.1182/bloodadvances.2021006922Test
    https://hdl.handle.net/11585/904780Test
    https://ashpublications.org/bloodadvances/article/6/12/3606/484368/Real-world-evidence-of-brexucabtagene-autoleucelTest

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Patients with aggressive B‐cell lymphoma receiving CAR T‐cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis.

    المؤلفون: Pernas, B.1,2 (AUTHOR) bertapernas@gmail.com, Iacoboni, G.3 (AUTHOR), Los‐Arcos, I.2 (AUTHOR), Carpio, C.3 (AUTHOR), Márquez‐Algaba, E.2 (AUTHOR), Sanchez‐Salinas, M. A.3 (AUTHOR), Albasanz, A.2 (AUTHOR), Esperalba, J.4,5 (AUTHOR), Viñado, B.4,5 (AUTHOR), Camps, I. Ruiz2,5 (AUTHOR), Barba, P.3 (AUTHOR) pbarba@vhio.net

    المصدر: European Journal of Haematology. Aug2024, Vol. 113 Issue 2, p227-234. 8p.


    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL

    المؤلفون: Rejeski, K., Perez, A., Iacoboni, G., Penack, O., Bücklein, V., Jentzsch, L., Mougiakakos, D., Johnson, G., Arciola, B., Carpio, C., Blumenberg, V., Hoster, E., Bullinger, L., Locke, F.L., von Bergwelt-Baildon, M., Mackensen, A., Bethge, W., Barba, P., Jain, M.D., Subklewe, M.

    مصطلحات موضوعية: Cancer Research

    وصف الملف: application/pdf

    العلاقة: http://edoc.mdc-berlin.de/21645/1/21645oa.pdfTest; The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. Rejeski, K. and Perez, A. and Iacoboni, G. and Penack, O. and Bücklein, V. and Jentzsch, L. and Mougiakakos, D. and Johnson, G. and Arciola, B. and Carpio, C. and Blumenberg, V. and Hoster, E. and Bullinger, L. and Locke, F.L. and von Bergwelt-Baildon, M. and Mackensen, A. and Bethge, W. and Barba, P. and Jain, M.D. and Subklewe, M. Journal for ImmunoTherapy of Cancer 10 (5): e004475. 17 May 2022

    الإتاحة: https://doi.org/10.1136/jitc-2021-004475Test
    http://edoc.mdc-berlin.de/21645Test/
    https://edoc.mdc-berlin.de/21645Test/
    http://edoc.mdc-berlin.de/21645/1/21645oa.pdfTest

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    S261: SAFETY AND PRELIMINARY EFFICACY FINDINGS OF AUTO4, A TRBC1-TARGETTING CAR, IN RELAPSED/REFRACTORY TRBC1 POSITIVE SELECTED T CELL NON-HODGKIN LYMPHOMA

    المؤلفون: Cwynarski, K., Tholouli, E., Iacoboni, G., Menne, T., Irvine, D., Wood, L., Balasubramaniam, N., Shang, J., Zhang, M, Duffy, K., Huber, B., Vinson, M., Brugger, W., Pule, M.

    المصدر: HemaSphere ; volume 6, page 162-163 ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000843936.81776.acTest

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    S220: GLOFITAMAB INDUCES DURABLE COMPLETE REMISSIONS AND HAS FAVORABLE SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AND ≥2 PRIOR THERAPIES: PIVOTAL PHASE II EXPANSION RESULTS

    المؤلفون: Dickinson, M., Carlo-Stella, C., Morschhauser, F., Bachy, E., Corradini, P., Iacoboni, G., Khan, C., Wróbel, T., Offner, F., Trněný, M., Wu, S.-J., Cartron, G., Hertzberg, M., Sureda, A., Perez-Callejo, D., Lundberg, L., Relf, J., Clark, E., Humphrey, K., Hutchings, M.

    المصدر: HemaSphere ; volume 6, page 121-122 ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000843772.15634.49Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

    المؤلفون: Bücklein, V., Perez, A., Iacoboni, G., Rejeski, K., Holtick, U., Penack, O., Kharboutli, S., Blumenberg, V., Ackermann, J., Frölich, L., Johnson, G., Patel, K., Arciola, B., Schmidt, C., Albanyan, O., Gödel, P., Hoster, E., Bullinger, L., Mackensen, A., Locke, F., von Bergwelt, M., Barba, P., Jain, M. D., Subklewe, M.

    المصدر: HemaSphere ; volume 6, page 1330-1331 ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000848644.19354.c7Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث